Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The DEEPER Trial - m-FOLFOXIRI + Cetuximab Treatment & Predictive Clinical Factors for RAS/BRAF Wild-Type and Left-Sided mCRC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Yu Sunakawa
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Yu Sunakawa
Login to view comments.
Click here to Login
Gastrointestinal